Literature DB >> 9568041

Expression of human papillomavirus type 16 L1 protein in Escherichia coli: denaturation, renaturation, and self-assembly of virus-like particles in vitro.

W Zhang1, J Carmichael, J Ferguson, S Inglis, H Ashrafian, M Stanley.   

Abstract

Major capsid protein L1 of HPV16 was produced in a fused form in Escherichia coli using an inducible expression system. The protein formed insoluble aggregations (inclusion bodies) and the yield was more than 10% of total cell proteins. The inclusion bodies were isolated and solubilised with 8 M urea and the L1 proteins were purified by chromatographic separation. Following removal of the urea by gradual dialysis, the denatured L1 proteins spontaneously renatured and subsequently assembled into polymorphologic aggregations in vitro. Electron microscopy showed that the assembled material included structures resembling native empty capsids as well as incompletely formed capsids. After separation from the pool of polymorphologic structures by sucrose gradient sedimentation, the correctly formed virus-like particles (VLE. coliPs) were recognised by a HPV16 type-specific, conformational-dependent monoclonal antibody in an ELISA. This system offers not only a model for investigation of the intrinsic interactions that occur during L1 assembly, but also a potential route for convenient manufacture of highly purified VLP vaccines.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9568041     DOI: 10.1006/viro.1998.9050

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  16 in total

1.  Production of human papillomavirus type 16 L1 virus-like particles by recombinant Lactobacillus casei cells.

Authors:  Karina Araujo Aires; Aurora Marques Cianciarullo; Sylvia Mendes Carneiro; Luisa Lina Villa; Enrique Boccardo; Gaspar Pérez-Martinez; Isabel Perez-Arellano; Maria Leonor Sarno Oliveira; Paulo Lee Ho
Journal:  Appl Environ Microbiol       Date:  2006-01       Impact factor: 4.792

Review 2.  Plant-derived virus-like particles as vaccines.

Authors:  Qiang Chen; Huafang Lai
Journal:  Hum Vaccin Immunother       Date:  2012-09-20       Impact factor: 3.452

3.  Immunization with a pentameric L1 fusion protein protects against papillomavirus infection.

Authors:  H Yuan; P A Estes; Y Chen; J Newsome; V A Olcese; R L Garcea; R Schlegel
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

4.  Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice.

Authors:  Peter Ohlschläger; Wolfram Osen; Kerstin Dell; Stefan Faath; Robert L Garcea; Ingrid Jochmus; Martin Müller; Michael Pawlita; Klaus Schäfer; Peter Sehr; Caroline Staib; Gerd Sutter; Lutz Gissmann
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

Review 5.  Replication and assembly of human papillomaviruses.

Authors:  M J Conway; C Meyers
Journal:  J Dent Res       Date:  2009-04       Impact factor: 6.116

6.  Expression and characterization of HPV-16 L1 capsid protein in Pichia pastoris.

Authors:  Silvia Boschi Bazan; Agtha de Alencar Muniz Chaves; Karina Araújo Aires; Aurora Marques Cianciarullo; Robert L Garcea; Paulo Lee Ho
Journal:  Arch Virol       Date:  2009-09-10       Impact factor: 2.574

Review 7.  Fluorosomes: fluorescent virus-like nanoparticles that represent a convenient tool to visualize receptor-ligand interactions.

Authors:  Daniela Wojta-Stremayr; Winfried F Pickl
Journal:  Sensors (Basel)       Date:  2013-07-08       Impact factor: 3.576

Review 8.  Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis C.

Authors:  Makutiro Ghislain Masavuli; Danushka K Wijesundara; Joseph Torresi; Eric J Gowans; Branka Grubor-Bauk
Journal:  Front Microbiol       Date:  2017-12-05       Impact factor: 5.640

9.  Translational fusion of chloroplast-expressed human papillomavirus type 16 L1 capsid protein enhances antigen accumulation in transplastomic tobacco.

Authors:  Paolo Lenzi; Nunzia Scotti; Fiammetta Alagna; Maria L Tornesello; Andrea Pompa; Alessandro Vitale; Angelo De Stradis; Luigi Monti; Stefania Grillo; Franco M Buonaguro; Pal Maliga; Teodoro Cardi
Journal:  Transgenic Res       Date:  2008-05-20       Impact factor: 3.145

Review 10.  Papillomavirus Infectious Pathways: A Comparison of Systems.

Authors:  Jennifer Biryukov; Craig Meyers
Journal:  Viruses       Date:  2015-08-04       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.